Literature DB >> 19031393

Can recent insights into cardiac development improve our understanding of congenitally malformed hearts?

Thomas Horsthuis1, Vincent M Christoffels, Robert H Anderson, Antoon F M Moorman.   

Abstract

Congenital cardiac malformations account for one-quarter of all human congenital abnormalities. They are caused by environmental and genetic factors. Despite increasing efforts in fundamental research, as yet, the morphogenesis of only a limited number of malformations has been elucidated. Over the last decades, new genetic modifications have made it possible to manipulate the mammalian embryo. Evidence provided using these transgenic techniques has, over the past decade, necessitated re-evaluation of several developmental processes, important in the understanding of normal as opposed to abnormal cardiac development. In this review, we discuss current understanding of the patterning of the initial heart tube, new insights into formation of the atrial and ventricular chambers, and novel information on the origin of the cells that are added to the heart after formation of the initial tube. All of these advances modify our appreciation of malformations involving the venous and arterial poles. As we demonstrate, this new information sheds light not only on normal cardiac development, but also explains the structure of several previously controversial lesions seen in malformed human hearts. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19031393     DOI: 10.1002/ca.20723

Source DB:  PubMed          Journal:  Clin Anat        ISSN: 0897-3806            Impact factor:   2.414


  9 in total

1.  Complex trait analysis of ventricular septal defects caused by Nkx2-5 mutation.

Authors:  Julia B Winston; Claire E Schulkey; Iuan-Bor D Chen; Suk D Regmi; Maria Efimova; Jonathan M Erlich; Courtney A Green; Ashley Aluko; Patrick Y Jay
Journal:  Circ Cardiovasc Genet       Date:  2012-04-24

2.  Retinoic acid regulates differentiation of the secondary heart field and TGFbeta-mediated outflow tract septation.

Authors:  Peng Li; Mohammad Pashmforoush; Henry M Sucov
Journal:  Dev Cell       Date:  2010-03-16       Impact factor: 12.270

3.  Rapid 3D phenotyping of cardiovascular development in mouse embryos by micro-CT with iodine staining.

Authors:  Karl Degenhardt; Alexander C Wright; Debra Horng; Arun Padmanabhan; Jonathan A Epstein
Journal:  Circ Cardiovasc Imaging       Date:  2010-02-27       Impact factor: 7.792

4.  A step-wise approach for analysis of the mouse embryonic heart using 17.6Tesla MRI.

Authors:  Rinat Gabbay-Benziv; E Albert Reece; Fang Wang; Amnon Bar-Shir; Chris Harman; Ozhan M Turan; Peixin Yang; Sifa Turan
Journal:  Magn Reson Imaging       Date:  2016-08-26       Impact factor: 2.546

Review 5.  Hierarchical approaches for systems modeling in cardiac development.

Authors:  Russell A Gould; Lina M Aboulmouna; Jeffrey D Varner; Jonathan T Butcher
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2013-03-05

6.  Expression of Foxm1 transcription factor in cardiomyocytes is required for myocardial development.

Authors:  Craig Bolte; Yufang Zhang; I-Ching Wang; Tanya V Kalin; Jeffrey D Molkentin; Vladimir V Kalinichenko
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

7.  Transposition of the great arteries: A laterality defect in the group of heterotaxy syndromes or an outflow tract malformation?

Authors:  Rana S Al-Zahrani; Samaher H Alharbi; Rawan M A Tuwaijri; Bayan T Alzomaili; Alaa Althubaiti; Talat Mesud Yelbuz
Journal:  Ann Pediatr Cardiol       Date:  2018 Sep-Dec

Review 8.  Molecular genetics of congenital atrial septal defects.

Authors:  Maximilian G Posch; Andreas Perrot; Felix Berger; Cemil Ozcelik
Journal:  Clin Res Cardiol       Date:  2009-12-11       Impact factor: 5.460

9.  Evo-Devo of the Human Vertebral Column: On Homeotic Transformations, Pathologies and Prenatal Selection.

Authors:  Clara M A Ten Broek; Alexander J Bakker; Irma Varela-Lasheras; Marianna Bugiani; Stefan Van Dongen; Frietson Galis
Journal:  Evol Biol       Date:  2012-08-18       Impact factor: 3.119

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.